Stifel Financial’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,033
| Closed | -$113K | – | 3378 |
|
|
2022
Q3 | $113K | Buy |
+17,033
| New | +$138K | ﹤0.01% | 3091 |
|
|
2022
Q2 | – | Sell |
-56,679
| Closed | -$1.08M | – | 3464 |
|
|
2022
Q1 | $1.08M | Buy |
56,679
+18,120
| +47% | +$285K | ﹤0.01% | 2057 |
|
|
2021
Q4 | $686K | Sell |
38,559
-7,285
| -16% | -$218K | ﹤0.01% | 2404 |
|
|
2021
Q3 | $1.7M | Sell |
45,844
-1,188
| -3% | -$52.7K | ﹤0.01% | 1692 |
|
|
2021
Q2 | $2.8M | Buy |
47,032
+3,517
| +8% | +$213K | ﹤0.01% | 1383 |
|
|
2021
Q1 | $2.92M | Buy |
43,515
+2,257
| +5% | +$177K | ﹤0.01% | 1271 |
|
|
2020
Q4 | $2.5M | Sell |
41,258
-10,776
| -21% | -$736K | ﹤0.01% | 1257 |
|
|
2020
Q3 | $4.11M | Sell |
52,034
-3,986
| -7% | -$318K | 0.01% | 863 |
|
|
2020
Q2 | $3.5M | Sell |
56,020
-7,161
| -11% | -$417K | 0.01% | 889 |
|
|
2020
Q1 | $3.35M | Buy |
63,181
+2,853
| +5% | +$283K | 0.01% | 815 |
|
|
2019
Q4 | $7.28M | Buy |
60,328
+6,279
| +12% | +$903K | 0.02% | 729 |
|
|
2019
Q3 | $9.83M | Buy |
54,049
+97
| +0.2% | +$13.7K | 0.03% | 553 |
|
|
2019
Q2 | $7.04M | Buy |
53,952
+8,194
| +18% | +$1.47M | 0.02% | 715 |
|
|
2019
Q1 | $11.1M | Sell |
45,758
-2,996
| -6% | -$793K | 0.03% | 499 |
|
|
2018
Q4 | $9.33M | Buy |
48,754
+7,284
| +18% | +$1.78M | 0.03% | 515 |
|
|
2018
Q3 | $13.6M | Buy |
41,470
+2,734
| +7% | +$838K | 0.04% | 413 |
|
|
2018
Q2 | $12M | Buy |
38,736
+1,483
| +4% | +$453K | 0.04% | 478 |
|
|
2018
Q1 | $9.07M | Buy |
37,253
+463
| +1% | +$130K | 0.03% | 565 |
|
|
2017
Q4 | $11.1M | Sell |
36,790
-4,008
| -10% | -$1.12M | 0.04% | 488 |
|
|
2017
Q3 | $10.8M | Sell |
40,798
-243
| -0.6% | -$70.3K | 0.04% | 476 |
|
|
2017
Q2 | $10.8M | Buy |
41,041
+32,454
| +378% | +$8.13M | 0.04% | 443 |
|
|
2017
Q1 | $3.09M | Buy |
8,587
+4,777
| +125% | +$1.48M | 0.01% | 895 |
|
|
2016
Q4 | $1.11M | Buy |
3,810
+3,218
| +544% | +$997K | ﹤0.01% | 1334 |
|
|
2016
Q3 | $197K | Sell |
592
-4,641
| -89% | -$1.69M | ﹤0.01% | 2189 |
|
|
2016
Q2 | $2.22M | Sell |
5,233
-312
| -6% | -$129K | 0.01% | 948 |
|
|
2016
Q1 | $1.77M | Sell |
5,545
-78
| -1% | -$26.6K | 0.01% | 972 |
|
|
2015
Q4 | $2.92M | Sell |
5,623
-451
| -7% | -$166K | 0.02% | 794 |
|
|
2015
Q3 | $1.78M | Sell |
6,074
-28
| -0.5% | -$9.95K | 0.01% | 962 |
|
|
2015
Q2 | $2.4M | Buy |
6,102
+1,460
| +31% | +$515K | 0.01% | 905 |
|
|
2015
Q1 | $1.4M | Buy |
4,642
+3,400
| +274% | +$830K | 0.01% | 1117 |
|
|
2014
Q4 | $276K | Buy |
1,242
+246
| +25% | +$50.7K | ﹤0.01% | 1919 |
|
|
2014
Q3 | $231K | Buy |
996
+347
| +53% | +$87.4K | ﹤0.01% | 1938 |
|
|
2014
Q2 | $143K | Sell |
649
-504
| -44% | -$112K | ﹤0.01% | 2058 |
|
|
2014
Q1 | $364K | Buy |
+1,153
| New | +$367K | ﹤0.01% | 1609 |
|
Other funds holding TXMD
RCMNY
TC
CC
BCM
Stifel Financial's TXMD Position: Q4 2022 in Review
Stifel Financial sold out of TherapeuticsMD (TXMD) in Q4 2022, closing a stake of 17,033 shares — an estimated $113K sold.
Stifel Financial first reported a position in TXMD in Q1 2014 and held it in 34 quarters. The position peaked at $13.6M in Q3 2018. 44 funds tracked by Wall St. Rank hold TXMD as of Q4 2022.
- Stifel Financial reported no remaining TherapeuticsMD position as of Q4 2022 after selling out during the quarter.
- Stifel Financial sold 17,033 TherapeuticsMD shares in Q4 2022, an estimated $113K.
- Stifel Financial first reported a position in TherapeuticsMD in Q1 2014 and held it in 34 quarters.
- Stifel Financial's TherapeuticsMD position peaked at $13.6M in Q3 2018.
- 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2022.
Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.